BIOMAT Database Logo BIOMAT Database Logo

Increased IgA natural autoantibody activity in sera of patients with homozygous beta-thalassaemia. 1990

P Lymberi, and A Aessopos, and M Karageorga, and D Hadzigianni, and D Loukopoulos, and P Kaklamanis

UI MeSH Term Description Entries
D007070 Immunoglobulin A Represents 15-20% of the human serum immunoglobulins, mostly as the 4-chain polymer in humans or dimer in other mammals. Secretory IgA (IMMUNOGLOBULIN A, SECRETORY) is the main immunoglobulin in secretions. IgA,IgA Antibody,IgA1,IgA2,Antibody, IgA
D007381 Intermediate Filament Proteins Filaments 7-11 nm in diameter found in the cytoplasm of all cells. Many specific proteins belong to this group, e.g., desmin, vimentin, prekeratin, decamin, skeletin, neurofilin, neurofilament protein, and glial fibrillary acid protein. Fibroblast Intermediate Filament Proteins,Filament Proteins, Intermediate,Proteins, Intermediate Filament
D008297 Male Males
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001323 Autoantibodies Antibodies that react with self-antigens (AUTOANTIGENS) of the organism that produced them. Autoantibody
D013789 Thalassemia A group of hereditary hemolytic anemias in which there is decreased synthesis of one or more hemoglobin polypeptide chains. There are several genetic types with clinical pictures ranging from barely detectable hematologic abnormality to severe and fatal anemia. Thalassemias
D065227 Transfusion Reaction Complications of BLOOD TRANSFUSION. Included adverse reactions are common allergic and febrile reactions; hemolytic (delayed and acute) reactions; and other non-hemolytic adverse reactions such as infections and adverse immune reactions related to immunocompatibility. Delayed Hemolytic Transfusion Reaction,Acute Hemolytic Transfusion Reaction,Blood Transfusion-Associated Adverse Reactions,Delayed Serologic Transfusion Reaction,Febrile Non-Hemolytic Transfusion Reaction,Hemolytic Transfusion Reaction,Hypotensive Transfusion Reaction,Post-Transfusion Purpura,Posttransfusion Purpura,TAGHD,Transfusion-Associated Allergic Reaction,Transfusion-Associated Circulatory Overload,Transfusion-Associated Dyspnea,Transfusion-Associated Graft Vs. Host Disease,Transfusion-Transmitted Infection,Allergic Reaction, Transfusion-Associated,Blood Transfusion Associated Adverse Reactions,Circulatory Overload, Transfusion-Associated,Circulatory Overloads, Transfusion-Associated,Dyspnea, Transfusion-Associated,Febrile Non Hemolytic Transfusion Reaction,Hemolytic Transfusion Reactions,Infection, Transfusion-Transmitted,Post Transfusion Purpura,Posttransfusion Purpuras,Purpura, Post-Transfusion,Purpura, Posttransfusion,Reaction, Hemolytic Transfusion,Reaction, Hypotensive Transfusion,Reactions, Hemolytic Transfusion,Transfusion Associated Allergic Reaction,Transfusion Associated Circulatory Overload,Transfusion Associated Dyspnea,Transfusion Associated Graft Vs. Host Disease,Transfusion Reaction, Hemolytic,Transfusion Reaction, Hypotensive,Transfusion Reactions,Transfusion Reactions, Hemolytic,Transfusion Reactions, Hypotensive,Transfusion Transmitted Infection,Transfusion-Associated Circulatory Overloads,Transfusion-Transmitted Infections

Related Publications

P Lymberi, and A Aessopos, and M Karageorga, and D Hadzigianni, and D Loukopoulos, and P Kaklamanis
Increased CA-15.3 levels in the serum of patients with homozygous beta-thalassaemia and sickle cell/beta-thalassaemia.
June 2006, British journal of haematology,
P Lymberi, and A Aessopos, and M Karageorga, and D Hadzigianni, and D Loukopoulos, and P Kaklamanis
Thyroid function in patients with homozygous beta-thalassaemia.
April 1984, Clinical endocrinology,
P Lymberi, and A Aessopos, and M Karageorga, and D Hadzigianni, and D Loukopoulos, and P Kaklamanis
Body proportions in patients with homozygous beta-thalassaemia.
December 1994, Acta paediatrica (Oslo, Norway : 1992). Supplement,
P Lymberi, and A Aessopos, and M Karageorga, and D Hadzigianni, and D Loukopoulos, and P Kaklamanis
[Psychosocial support of patients with homozygous beta-thalassaemia].
January 2000, Klinische Padiatrie,
P Lymberi, and A Aessopos, and M Karageorga, and D Hadzigianni, and D Loukopoulos, and P Kaklamanis
A unique thalassaemic syndrome: homozygous alpha-thalassaemia + homozygous beta-thalassaemia.
July 1978, British journal of haematology,
P Lymberi, and A Aessopos, and M Karageorga, and D Hadzigianni, and D Loukopoulos, and P Kaklamanis
Homozygous beta thalassaemia in Liberia.
June 1975, Journal of medical genetics,
P Lymberi, and A Aessopos, and M Karageorga, and D Hadzigianni, and D Loukopoulos, and P Kaklamanis
Myoglobin in homozygous beta-thalassaemia.
January 1974, Acta haematologica,
P Lymberi, and A Aessopos, and M Karageorga, and D Hadzigianni, and D Loukopoulos, and P Kaklamanis
Homozygous beta thalassaemia in Egypt.
January 1981, Hereditas,
P Lymberi, and A Aessopos, and M Karageorga, and D Hadzigianni, and D Loukopoulos, and P Kaklamanis
Plasma cyclic nucleotide levels in patients with homozygous beta-thalassaemia.
April 1985, Scandinavian journal of haematology,
P Lymberi, and A Aessopos, and M Karageorga, and D Hadzigianni, and D Loukopoulos, and P Kaklamanis
Increased natural autoantibody activity to cytoskeleton proteins in sera from patients with necrobiosis lipoidica, with or without insulin-dependent diabetes mellitus.
January 1995, Autoimmunity,
Copied contents to your clipboard!